Showing results (591-600 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|June 20, 2008
Generic entry, reformulations and promotion of SSRIs in the USHaiden A Huskamp, Julie M Donohue, Catherine Koss, et al.Pharmacoeconomics|April 21, 2010
Economic content in medical journal advertisements for medical devices and prescription drugsD Clay Ackerly, Seth W Glickman, Kevin A SchulmanPharmacoeconomics|April 12, 2006
The burden of age-related macular degenerationJordana K Schmier, Mechelle L Jones, Michael T HalpernPharmacoeconomics|April 12, 2006
Optimal assignment of treatments to health states using a Markov decision model: an introduction to basic conceptsMohan V Bala, Josephine A MauskopfPharmacoeconomics|May 8, 2010
Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trialEdward C F Wilson, David Price, Stanley D Musgrave, et al.Pharmacoeconomics|October 28, 2006
Building bridges between academic research and policy formulation: the PRUFE framework - an integral part of Ontario's evidence-based HTPA processRon Goeree, Leslie LevinPharmacoeconomics|March 4, 2009
Economics of treatments for non-small cell lung cancerChristos Chouaid, Kukovi Atsou, Gilles Hejblum, et al.Pharmacoeconomics|March 4, 2009
Willingness to pay for a treatment for pain in multiple sclerosisMichael Iskedjian, Olivier Desjardins, Charles Piwko, et al.Pharmacoeconomics|June 3, 2009
Economic and human costs of restless legs syndromeThomas Reinhold, Falk Müller-Riemenschneider, Stefan N Willich, et al.Pharmacoeconomics|June 3, 2009
Willingness to pay for cancer preventionTimothy L Hunt, Bryan R Luce, Matthew J Page, et al.Pageof 335